First National Trust Co Sells 113 Shares of Colgate-Palmolive (NYSE:CL)

First National Trust Co lowered its holdings in shares of Colgate-Palmolive (NYSE:CL) by 2.5% during the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 4,429 shares of the company’s stock after selling 113 shares during the quarter. First National Trust Co’s holdings in Colgate-Palmolive were worth $460,000 at the end of the most recent quarter.

Several other institutional investors have also modified their holdings of CL. E Fund Management Hong Kong Co. Ltd. bought a new position in Colgate-Palmolive in the second quarter valued at approximately $25,000. Continuum Advisory LLC lifted its position in Colgate-Palmolive by 46.5% in the 2nd quarter. Continuum Advisory LLC now owns 394 shares of the company’s stock valued at $38,000 after acquiring an additional 125 shares in the last quarter. Reston Wealth Management LLC bought a new position in Colgate-Palmolive during the 3rd quarter worth about $42,000. Capital Performance Advisors LLP bought a new position in Colgate-Palmolive during the 3rd quarter worth about $53,000. Finally, Gradient Investments LLC raised its stake in shares of Colgate-Palmolive by 150.4% in the 2nd quarter. Gradient Investments LLC now owns 666 shares of the company’s stock valued at $65,000 after purchasing an additional 400 shares during the period. Institutional investors own 80.41% of the company’s stock.

Analyst Ratings Changes

A number of research analysts recently issued reports on CL shares. Barclays increased their price objective on Colgate-Palmolive from $91.00 to $96.00 and gave the stock an “equal weight” rating in a report on Monday, July 29th. JPMorgan Chase & Co. lifted their price objective on shares of Colgate-Palmolive from $113.00 to $114.00 and gave the company an “overweight” rating in a report on Friday, October 11th. Piper Sandler assumed coverage on shares of Colgate-Palmolive in a research report on Tuesday, September 24th. They issued an “overweight” rating and a $121.00 target price for the company. TD Cowen cut their price target on shares of Colgate-Palmolive from $115.00 to $110.00 and set a “buy” rating on the stock in a research report on Monday, October 28th. Finally, Evercore ISI raised their price objective on Colgate-Palmolive from $100.00 to $106.00 and gave the company an “outperform” rating in a report on Thursday, July 18th. One investment analyst has rated the stock with a sell rating, nine have assigned a hold rating and thirteen have assigned a buy rating to the company. According to MarketBeat, the stock has a consensus rating of “Moderate Buy” and a consensus target price of $105.11.

Insider Activity at Colgate-Palmolive

In other news, Director Martina Hundmejean sold 2,313 shares of the business’s stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the completion of the sale, the director now owns 11,755 shares in the company, valued at $1,220,874.30. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available at this hyperlink. In other Colgate-Palmolive news, CFO Stanley J. Sutula III sold 45,410 shares of Colgate-Palmolive stock in a transaction dated Tuesday, November 5th. The shares were sold at an average price of $94.11, for a total value of $4,273,535.10. Following the completion of the sale, the chief financial officer now owns 36,726 shares in the company, valued at $3,456,283.86. The trade was a 0.00 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, Director Martina Hundmejean sold 2,313 shares of the stock in a transaction that occurred on Friday, August 23rd. The stock was sold at an average price of $103.86, for a total transaction of $240,228.18. Following the transaction, the director now owns 11,755 shares in the company, valued at approximately $1,220,874.30. The trade was a 0.00 % decrease in their position. The disclosure for this sale can be found here. 0.34% of the stock is owned by company insiders.

Colgate-Palmolive Trading Down 0.5 %

Shares of Colgate-Palmolive stock opened at $91.08 on Thursday. Colgate-Palmolive has a 1 year low of $75.17 and a 1 year high of $109.30. The company has a market capitalization of $74.41 billion, a price-to-earnings ratio of 26.10, a P/E/G ratio of 3.27 and a beta of 0.42. The business has a fifty day simple moving average of $100.30 and a two-hundred day simple moving average of $98.53. The company has a debt-to-equity ratio of 9.46, a current ratio of 1.04 and a quick ratio of 0.68.

Colgate-Palmolive Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Investors of record on Friday, October 18th will be issued a dividend of $0.50 per share. This represents a $2.00 annualized dividend and a dividend yield of 2.20%. The ex-dividend date of this dividend is Friday, October 18th. Colgate-Palmolive’s payout ratio is 57.31%.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company, together with its subsidiaries, manufactures and sells consumer products in the United States and internationally. It operates through two segments: Oral, Personal and Home Care; and Pet Nutrition. The Oral, Personal and Home Care segment offers toothpaste, toothbrushes, mouthwash, bar and liquid hand soaps, shower gels, shampoos, conditioners, deodorants and antiperspirants, skin health products, dishwashing detergents, fabric conditioners, household cleaners, and other related items.